TrialPloS one2021

A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

Ji Bak Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.